×
You've used up your 3 free articles for this month. Subscribe today.
Suboxone Manufacturer’s Delayed-Release Buprenorphine Injections Show Promise at Maine Jail
The stock price of Richmond, Virginia-based Indivior PLC was down 20% in the first 12 days of February 2025, after delayed approval from the federal Food & Drug Administration (FDA) of label changes on its Sublocade medication—a single injection that provides a 28-day extended-release dosage of buprenorphine for those recovering ...
Full article and associated cases available to subscribers.
As a digital subscriber to Prison Legal News, you can access full text and downloads for this and other premium content.
Already a subscriber? Login